By Ed Silverman
“At issue is growing unease that some Covid-19 medical products may not be accessible for poorer populations across the globe. The U.S. National Institutes of Health, for instance, plans to assemble a public-private partnership to coordinate research. But Public Citizen is urging the NIH to avoid allowing monopolies and commit to non-exclusive licensing for treatments and vaccines in exchange for royalties.”
Read the full story here.